APA (7th ed.) Citation

Taub, R., Chiang, E., Chabot-Blanchet, M., Kelly, M. J., Reeves, R. A., Guertin, M., & Tardif, J. (2013). Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist. Atherosclerosis, 230(2), 373-380. https://doi.org/10.1016/j.atherosclerosis.2013.07.056

Chicago Style (17th ed.) Citation

Taub, Rebecca, Edward Chiang, Malorie Chabot-Blanchet, Martha J. Kelly, Richard A. Reeves, Marie-Claude Guertin, and Jean-Claude Tardif. "Lipid Lowering in Healthy Volunteers Treated with Multiple Doses of MGL-3196, a Liver-targeted Thyroid Hormone Receptor-β Agonist." Atherosclerosis 230, no. 2 (2013): 373-380. https://doi.org/10.1016/j.atherosclerosis.2013.07.056.

MLA (9th ed.) Citation

Taub, Rebecca, et al. "Lipid Lowering in Healthy Volunteers Treated with Multiple Doses of MGL-3196, a Liver-targeted Thyroid Hormone Receptor-β Agonist." Atherosclerosis, vol. 230, no. 2, 2013, pp. 373-380, https://doi.org/10.1016/j.atherosclerosis.2013.07.056.